Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-24 @ 1:21 PM
NCT ID:
NCT01051895
Eligibility Criteria:
Inclusion Criteria:
* Woman ≥ 18 years old 19 in British Columbia, Nova Scotia and Newfoundland)
* Understands English or French (for sites where French speaking coordinator is available)
* Is treated for biopsy proven CIN II, III or AIS
* Understands study procedures, available alternatives treatment, risks related to study, and accepts voluntarily to participate by signing the ICF.
Exclusion Criteria:
* has been treated for cervical cancer or pre-cancer in the past
* Participant has known immunosuppression or immunodeficiency
* Planned hysterectomy
* Participant is receiving or has received one of the following treatment :
* Immunosuppressive therapy in the three months prior to enrollment
* Corticosteroid therapy in the two weeks prior to enrollment
* Two or more courses of corticosteroids (orally or parenterally) lasting at least one week in duration in the year prior to enrollment (inhalation, nasal or topical corticosteroids are permitted)
* There is a strong probability that the participant will not follow the procedures of study, will not come to its appointment, or plans a delocalization throughout study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01051895
Study Brief:
Protocol Section:
NCT01051895